News for CG oncology Inc Stock (CGON)

CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates

GlobeNewsWire • Thursday

CG Oncology: ASCO Play And Top-Line Data End Of 2024 Could Drive Further Value

Seeking Alpha • Monday

Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

GlobeNewsWire • 05/03/24

CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024

GlobeNewsWire • 04/26/24

CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024

GlobeNewsWire • 04/24/24

CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting

GlobeNewsWire • 03/28/24

How to Find Up-and-Coming Stocks to Buy Right Now

Zacks Investment Research • 03/19/24

Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys?

The Motley Fool • 02/25/24

Protara: A Bombed Out Biotech With A Very Positive Skew

Seeking Alpha • 02/22/24

3 attractive stocks that insiders are buying

InsiderTrades • 02/12/24

Insider Buying at These Biotechs Is Huge

24/7 Wall Street • 02/05/24

CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Business Wire • 01/30/24

American Healthcare REIT, Fortegra and Fractyle Health set IPO price ranges as thaw continues

Market Watch • 01/29/24

U.S. IPO Weekly Recap: Biotech CG Oncology Pops 96% In A 7 IPO Week

Seeking Alpha • 01/27/24

Biotech's First IPO of 2024 Popped 96%. What It Means.

Barrons • 01/26/24

CG Oncology's Lead Bladder Cancer Drug Offers A Strong Potential Revenue Stream With Buyout Optionality

Seeking Alpha • 01/25/24

CG Oncology valued at $1.75 bln in strong market debut

Reuters • 01/25/24

CG Oncology IPO prices above range and boosts share count in bullish move ahead of trading

Market Watch • 01/25/24

CG Oncology Announces Pricing of Upsized Initial Public Offering

Business Wire • 01/25/24